Evidence map›Paper›PMID 25964427›Full record

ArticleHuman molecular genetics2015

Mitochondrial DNA variants can mediate methylation status of inflammation, angiogenesis and signaling genes.

Shari R Atilano, Deepika Malik, Marilyn Chwa, Javier Cáceres-Del-Carpio, Anthony B Nesburn, David S Boyer, Baruch D Kuppermann, S Michal Jazwinski, Michael V Miceli, Douglas C Wallace and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Human molecular genetics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 1 pooled it
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 1 synthesis or guideline pooled it, 59 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Cyclic GMP-AMP Synthase in Cancer Prevention.Journal of cancer prevention · 2023
    Review
  13. Review
  14. Article
  15. Article
  16. Mitochondrial Epigenetics Regulating Inflammation in Cancer and Aging.Frontiers in cell and developmental biology · 2022
    Review
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Shari R AtilanoGavin Herbert Eye Institute and.
Deepika MalikGavin Herbert Eye Institute and.
Marilyn ChwaGavin Herbert Eye Institute and.
Javier Cáceres-Del-CarpioGavin Herbert Eye Institute and.
Anthony B NesburnGavin Herbert Eye Institute and Cedars-Sinai Medical Center, Los Angeles, CA, USA.
David S BoyerRetina-Vitreous Associates Medical Group, Beverly Hills, CA 90211, USA.
Baruch D KuppermannGavin Herbert Eye Institute and.
S Michal JazwinskiTulane Center for Aging and Department of Medicine, Tulane University, New Orleans, LA 70118, USA and.
Michael V MiceliTulane Center for Aging and Department of Medicine, Tulane University, New Orleans, LA 70118, USA and.
Douglas C WallaceCenter of Mitochondrial and Epigenomic Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
Nitin UdarGavin Herbert Eye Institute and.
M Cristina KenneyGavin Herbert Eye Institute and Department of Pathology and Laboratory Medicine, University of California Irvine, Irvine, CA 92697, USA, mkenney@uci.edu.
Tulane University · USCedars-Sinai Medical Center · USChildren's Hospital of Philadelphia · USRetina Vitreous Associates Medical Group · USUniversity of California, Irvine · US

Funding

University of California Health Participation in the National COVID Cohort Collaborative (N3C)UL1TR001414 · NCATS · UNIVERSITY OF CALIFORNIA-IRVINE · PI COOPER, DAN M, VILAIN, ERIC J. · 2015 to 2023
$35.1M
MITOCHONDRIAL INBORN ERRORS OF METABOLISMR01NS021328 · NINDS · UNIVERSITY OF CALIFORNIA-IRVINE · PI WALLACE, DOUGLAS C · 1985 to 2017
$6.5M
CELLULAR AGING IN A YEAST MODEL SYSTEMR37AG006168 · NIA · TULANE UNIVERSITY OF LOUISIANA · PI JAZWINSKI, S MICHAL · 1994 to 2016
$5.0M
NCATS NIH HHS UL1 TR001414NIA NIH HHS R37 AG006168NINDS NIH HHS R01 NS021328
6 · The paper itself

Abstract

Mitochondrial (mt) DNA can be classified into haplogroups representing different geographic and/or racial origins of populations. The H haplogroup is protective against age-related macular degeneration (AMD), while the J haplogroup is high risk for AMD. In the present study, we performed comparison analyses of human retinal cell cybrids, which possess identical nuclei, but mtDNA from subjects with either the H or J haplogroups, and demonstrate differences in total global methylation, and expression patterns for two genes related to acetylation and five genes related to methylation. Analyses revealed that untreated-H and -J cybrids have different expression levels for nuclear genes (CFH, EFEMP1, VEGFA and NFkB2). However, expression levels for these genes become equivalent after treatment with a methylation inhibitor, 5-aza-2'-deoxycytidine. Moreover, sequencing of the entire mtDNA suggests that differences in epigenetic status found in cybrids are likely due to single nucleotide polymorphisms (SNPs) within the haplogroup profiles rather than rare variants or private SNPs. In conclusion, our findings indicate that mtDNA variants can mediate methylation profiles and transcription for inflammation, angiogenesis and various signaling pathways, which are important in several common diseases.

Indexed as

Polymorphism, Single NucleotideCell LineDNA MethylationDNA, MitochondrialDrugs, Chinese HerbalFemaleHumansInflammationMaleNeovascularization, PathologicSignal Transductionchan-yu-bao-yuan-tangDNA, MitochondrialDrugs, Chinese Herbal

Identifiers

PMID25964427
PMCPMC4512622
OpenAlexW1938364190

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.